| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ad4c9403364a2277dc906d5bc5642e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90274 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-60 |
| filingDate |
2019-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b0a9f0c5e8b0aa3a4a939f3f0845cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb0d770db6e616101b530069d55c9486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2cbdb932fba87cd21ad3fb29f4ef2d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44db26dc8b5a6c8b981839d61931efaf |
| publicationDate |
2019-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190139796-A |
| titleOfInvention |
Composition for diagnosing cyclooxygenase 2 over-expressed disease and method for screening thereof |
| abstract |
The present invention relates to a composition for diagnosing COX2 (cyclooxygenase 2) overexpression disease and a screening method thereof, and more particularly to a composition for diagnosing COX2 overexpression disease comprising a compound having a structural characteristic exhibiting a strong binding activity to COX2 protein and a screening method thereof It is about. The compound provided by the present invention is very excellent in binding ability with COX2 and very high blood-brain barrier (BBB) permeability can be very useful for the diagnosis and prediction of the prognosis of COX2 overexpressing diseases including degenerative neurological diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210034532-A |
| priorityDate |
2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |